LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--May 10, 2006--BioSante Pharmaceuticals, Inc. (Amex:BPA - News) today announced that Stephen M. Simes, the company’s president and chief executive officer, will present a corporate overview including a summary of Bio-E-Gel®, BioSante’s transdermal estradiol gel for the treatment of menopausal symptoms in women, at Rodman & Renshaw’s 3rd Annual Global Healthcare Conference in Monte Carlo, Monaco. The presentation will take place on Monday, May 15, at 3:40 p.m. CEST (9:40 a.m. EDT).
